Combining Fluvoxamine and Lisdexamfetamine: Safety Considerations

Potential Interactions and Risks

The American Academy of Child and Adolescent Psychiatry advises caution when combining fluvoxamine and lisdexamfetamine due to potential drug interactions and increased risk of serotonin syndrome, requiring careful dosing, monitoring, and awareness of potential adverse effects 1, 2
Fluvoxamine has substantial pharmacological interactions with many medications due to its inhibitory effects on multiple cytochrome P450 enzymes, including CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6, which can increase the risk of adverse effects when combined with other medications 1, 3
Combining serotonergic drugs like fluvoxamine with stimulants like lisdexamfetamine/Vyvanse increases the risk of serotonin syndrome, which can manifest as mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity 1, 2
Serotonin syndrome symptoms can develop within 24-48 hours after combining medications and may include mental status changes, such as confusion, agitation, and anxiety, as well as neuromuscular symptoms like tremors, clonus, and hyperreflexia, and autonomic symptoms like hypertension, tachycardia, and diaphoresis 1
Advanced symptoms of serotonin syndrome can include fever, seizures, arrhythmias, and unconsciousness, which can potentially be fatal 1

When combining fluvoxamine and lisdexamfetamine, the American Academy of Child and Adolescent Psychiatry recommends starting the second serotonergic drug at a low dose and increasing it slowly and gradually, while monitoring closely for symptoms of serotonin syndrome, especially in the first 24-48 hours after dosage changes 1, 2
Fluvoxamine may alter the metabolism of lisdexamfetamine through its effects on CYP enzymes, potentially leading to higher-than-expected levels of the active amphetamine metabolite, highlighting the need for careful dosing and monitoring 3
Therapeutic drug monitoring is recommended if available, as fluvoxamine has a recommended therapeutic range of 150-300 ng/mL, to minimize the risk of adverse effects 4

Patients with pre-existing cardiovascular conditions require additional caution when combining fluvoxamine and lisdexamfetamine, as both medications can affect heart rate and blood pressure, increasing the risk of cardiovascular adverse effects 1
The combination of fluvoxamine and lisdexamfetamine may potentially exacerbate anxiety or agitation, which can be initial adverse effects of SSRIs like fluvoxamine, highlighting the need for close monitoring and adjustment of treatment as needed 2
Fluvoxamine has been associated with discontinuation syndrome, so any future medication adjustments should involve slow tapering to minimize the risk of withdrawal symptoms 1, 3

If the combination of fluvoxamine and lisdexamfetamine is necessary for treating comorbid conditions, alternative medications with fewer drug interactions, such as citalopram or escitalopram, may be considered, as they have less effect on CYP450 isoenzymes compared to fluvoxamine 1
Non-stimulant ADHD medications might be considered if appropriate for the patient's condition, to minimize the risk of drug interactions and adverse effects 2
Medical education, training, and experience are necessary to safely and effectively prescribe these medications in combination, highlighting the need for healthcare professionals to be aware of the potential risks and benefits of combining fluvoxamine and lisdexamfetamine 1